Skip to content

Study · Not a test of the peptide alone · 2003

1 result

Interaction of myosin subfragment 1 with forms of monomeric actin.

Ballweber E, Kiessling P, Manstein D, Mannherz HG

Biochemistry1 Mar 2003Cited by 1 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin beta-4 (human).

  1. 01LabNot a test of Thymosin beta-4 (human) aloneIn vitro (cell-free)Mechanism

    Fluorescence titration showed that myosin subfragment 1 bound to actin in complex with thymosin beta4 or DNase I.

    In plain wordsIn lab tests, a myosin fragment bound to actin that was held by thymosin beta4.

    Outcome
    Not applicableMyosin subfragment 1 binding to actin-thymosin beta4 complex
    Study

    n: not reported in source

    Purified proteins, fluorescence titration
    Outcome group
    Receptor activity and mechanism · Whole body

    Source sentences

    Summary
    Fluorescence titration employing pyrenyl-actin in complex with deoxyribonuclease I (DNase I) or thymosin beta4 demonstrated S1 binding to these actin complexes.
    1 context sentence
    Summary · context
    The ability of myosin subfragment 1 to interact with monomeric actin complexed to sequestering proteins was tested by a number of different techniques such as affinity absorption, chemical cross-linking, fluorescence titration, and competition procedures.

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.